| 2062_AT |
IGFBP7 |
G | | D | | | | | | |
 |
 |
insulin-like growth factor binding protein 7 |
| 226_AT |
PRKAR1A |
| | | | | P | R | | S |
 |
 |
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) |
| 38673_S_AT |
CDKN1C |
G | | | | | P | | | |
 |
 |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| 37187_AT |
CXCL2 |
| | | X | | | | | S |
 |
 |
chemokine (C-X-C motif) ligand 2 |
| 40418_AT |
RBBP4 |
G | | | X | | | R | | |
 |
 |
retinoblastoma binding protein 4 |
| 1911_S_AT |
GADD45A |
G | | | X | | P | | | |
 |
 |
growth arrest and DNA-damage-inducible, alpha |
| 41759_AT |
SKP1A |
G | | | | | | R | | |
 |
 |
S-phase kinase-associated protein 1A (p19A) |
| 227_G_AT |
PRKAR1A |
| | | | | P | R | | S |
 |
 |
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) |
| 33113_AT |
CITED2 |
| | | | | | R | | |
 |
 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
| 39545_AT |
CDKN1C |
G | | | | | P | | | |
 |
 |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| 32775_R_AT |
PLSCR1 |
| | | | | | | | |
 |
 |
phospholipid scramblase 1 |
| 36629_AT |
DSIPI |
| | | | | | R | | |
 |
 |
delta sleep inducing peptide, immunoreactor |
| 1787_AT |
CDKN1C |
G | | | | | P | | | |
 |
 |
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| 34642_AT |
YWHAZ |
| | | | | | | | |
 |
 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
| 1235_AT |
YWHAZ |
| | | | | | | | |
 |
 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |